Troy Cox - 18 Jun 2026 Form 4 Insider Report for SOPHiA GENETICS SA (SOPH)

Reporting relationship: Director
Issuer ticker: SOPH
Reported as of: 18 Jun 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 22 Jun 2026, 16:01:51 UTC
Prior SEC filing: 18 Mar 2026
Next SEC filing: 25 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Elimara Brunetto as Attorney-in-Fact for Troy Cox

Key filing fact

Troy Cox filed Form 4 for SOPHiA GENETICS SA (SOPH) on 22 Jun 2026.

Key facts

This page summarizes Troy Cox's Form 4 filing for SOPHiA GENETICS SA (SOPH).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 22 Jun 2026, 16:01.

Change

Previous filing in this sequence was filed on 18 Mar 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001696923 Primary reporting owner

Cox Troy

Relationship: Director
Address: C/O SOPHIA GENETICS INC., 401 PARK DRIVE, FLOOR 5, BOSTON
Signature: /s/ Elimara Brunetto as Attorney-in-Fact for Troy Cox
Signature date: 22 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

SOPH transaction

Ordinary Shares

Award

Transaction value
Shares: +19,724
Change %: +6.4%
Price: $5.46^*
Shares after: 328,743
Date: 18 Jun 2026
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

SOPH transaction Derivative

Share Option (Right to Buy)

Award

Transaction value
Shares: +28,818
Change %: +13%
Price: $5.46^*
Shares after: 252,809
Date: 18 Jun 2026
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 28,818
Exercise price: $5.46
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Represents a restricted stock unit ("RSU") grant. Each RSU represents a contingent right to receive one ordinary share of the Issuer, subject to Reporting Person's continued service with the Issuer. The RSUs were granted on June 18, 2026 and vest 100% as of the date of the Issuer's next scheduled annual meeting of shareholders.

Footnote F2

The share options were granted on June 18, 2026 and vest 100% as of the date of the Issuer's next scheduled annual meeting of shareholders, subject to the Reporting Person's continued service to the Issuer through the relevant vesting date.